Table 2.
Group | Variable | n | Mean | CI | SD | Min‐Max |
---|---|---|---|---|---|---|
No adverse reaction | Age (years) | 182 | 4.4 | 3.9–5.0 | 3.6 | 0.1–22.3 |
Body weight (kg) | 181 | 471 | 455–487 | 112 | 146–700 | |
Neurologic signs (days) | 141 | 168 | 104–232 | 387 | 1–4015 | |
CSF volume removed (mL) | 46 | 44 | 40–48 | 13 | 0–60 | |
Contrast volume (mL) | 152 | 52 | 50–54 | 12 | 15–80 | |
Contrast dose (mL/kg) | 151 | 0.12 | 0.11–0.12 | 0.03 | 0.03–0.28 | |
Precontrast MAP (mmHg) | 159 | 80 | 78–83 | 14 | 45–125 | |
Postcontrast MAP (mmHg) | 176 | 78 | 76–79 | 9.5 | 58–112 | |
Myelography (minutes) | 175 | 64 | 60–67 | 25 | 10–160 | |
Anesthesia (minutes) | 180 | 96 | 91–100 | 31 | 45–205 | |
Recovery (minutes) | 122 | 46 | 42–50 | 23 | 10–159 | |
Hospitalization (days) | 146 | 4 | 3–6 | 7 | 0–49 | |
Any adverse reaction | Age (years) | 94 | 4.9 | 4.2–5.6 | 3.4 | 0.1–13.7 |
Body weight (kg) | 95 | 487 | 463–510 | 116 | 109–739 | |
Neurologic signs (days) | 75 | 155 | 105–205 | 218 | 1–900 | |
CSF volume removed (mL) | 14 | 49 | 45–54 | 8 | 30–60 | |
Contrast volume (mL) | 69 | 56 | 53–60 | 15 | 30–110 | |
Contrast dose (mL/kg) | 69 | 0.12 | 0.11–0.14 | 0.05 | 0.07–0.37 | |
Precontrast MAP (mmHg) | 80 | 82 | 79–85 | 15 | 53–137 | |
Postcontrast MAP (mmHg) | 95 | 79 | 77–82 | 13 | 55–128 | |
Myelography (minutes) | 92 | 71 | 65–76 | 27 | 30–150 | |
Anesthesia (minutes) | 94 | 101 | 95–107 | 30 | 50–190 | |
Recovery (minutes) | 78 | 55 | 49–62 | 27 | 19–205 | |
Hospitalization (days) | 91 | 8 | 5–10 | 12 | 0–60 |
n, number; CI, 95% confidence interval; SD, standard deviation; Min, minimum; Max, maximum; MAP, mean arterial pressure.
Precontrast MAP is the average for the 10 minutes before contrast‐medium injection. Postcontrast MAP is the average for 0–20 minutes following contrast‐medium injection.